These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 21097672)

  • 21. CCL2 and CCR2 are Essential for the Formation of Osteoclasts and Foreign Body Giant Cells.
    Khan UA; Hashimi SM; Bakr MM; Forwood MR; Morrison NA
    J Cell Biochem; 2016 Feb; 117(2):382-9. PubMed ID: 26205994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemokine signals are crucial for enhanced homing and differentiation of circulating osteoclast progenitor cells.
    Sucur A; Jajic Z; Artukovic M; Matijasevic MI; Anic B; Flegar D; Markotic A; Kelava T; Ivcevic S; Kovacic N; Katavic V; Grcevic D
    Arthritis Res Ther; 2017 Jun; 19(1):142. PubMed ID: 28619088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen-dependent and C-C chemokine receptor-2-dependent pathways determine osteoclast behavior in osteoporosis.
    Binder NB; Niederreiter B; Hoffmann O; Stange R; Pap T; Stulnig TM; Mack M; Erben RG; Smolen JS; Redlich K
    Nat Med; 2009 Apr; 15(4):417-24. PubMed ID: 19330010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of the bone marrow microenvironment in multiple myeloma.
    Roodman GD
    J Bone Miner Res; 2002 Nov; 17(11):1921-5. PubMed ID: 12412796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deletion of FGFR3 in Osteoclast Lineage Cells Results in Increased Bone Mass in Mice by Inhibiting Osteoclastic Bone Resorption.
    Su N; Li X; Tang Y; Yang J; Wen X; Guo J; Tang J; Du X; Chen L
    J Bone Miner Res; 2016 Sep; 31(9):1676-87. PubMed ID: 26990430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemokine receptor CCR2 is expressed by human multiple myeloma cells and mediates migration to bone marrow stromal cell-produced monocyte chemotactic proteins MCP-1, -2 and -3.
    Vande Broek I; Asosingh K; Vanderkerken K; Straetmans N; Van Camp B; Van Riet I
    Br J Cancer; 2003 Mar; 88(6):855-62. PubMed ID: 12644822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions of myeloma cells with osteoclasts promote tumour expansion and bone degradation through activation of a complex signalling network and upregulation of cathepsin K, matrix metalloproteinases (MMPs) and urokinase plasminogen activator (uPA).
    Hecht M; von Metzler I; Sack K; Kaiser M; Sezer O
    Exp Cell Res; 2008 Mar; 314(5):1082-93. PubMed ID: 18053985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimulatory effect of insulin-like growth factor binding protein-5 on mouse osteoclast formation and osteoclastic bone-resorbing activity.
    Kanatani M; Sugimoto T; Nishiyama K; Chihara K
    J Bone Miner Res; 2000 May; 15(5):902-10. PubMed ID: 10804020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteoclast-like cell formation by circulating myeloma B lymphocytes: role of RANK-L.
    Calvani N; Silvestris F; Cafforio P; Dammacco F
    Leuk Lymphoma; 2004 Feb; 45(2):377-80. PubMed ID: 15101727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
    Yu X; Huang Y; Collin-Osdoby P; Osdoby P
    J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myeloma cell-induced disruption of bone remodelling compartments leads to osteolytic lesions and generation of osteoclast-myeloma hybrid cells.
    Andersen TL; Søe K; Sondergaard TE; Plesner T; Delaisse JM
    Br J Haematol; 2010 Feb; 148(4):551-61. PubMed ID: 19919653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity.
    Conaway HH; Henning P; Lie A; Tuckermann J; Lerner UH
    Bone; 2016 Dec; 93():43-54. PubMed ID: 27596806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased osteocyte death in multiple myeloma patients: role in myeloma-induced osteoclast formation.
    Giuliani N; Ferretti M; Bolzoni M; Storti P; Lazzaretti M; Dalla Palma B; Bonomini S; Martella E; Agnelli L; Neri A; Ceccarelli F; Palumbo C
    Leukemia; 2012 Jun; 26(6):1391-401. PubMed ID: 22289923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chondroitin synthase 1 is a key molecule in myeloma cell-osteoclast interactions.
    Yin L
    J Biol Chem; 2005 Apr; 280(16):15666-72. PubMed ID: 15485809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of CCR2 in orthodontic tooth movement.
    Taddei SR; Andrade I; Queiroz-Junior CM; Garlet TP; Garlet GP; Cunha Fde Q; Teixeira MM; da Silva TA
    Am J Orthod Dentofacial Orthop; 2012 Feb; 141(2):153-60. PubMed ID: 22284282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PDK1 is important lipid kinase for RANKL-induced osteoclast formation and function via the regulation of the Akt-GSK3β-NFATc1 signaling cascade.
    Xiao D; Zhou Q; Gao Y; Cao B; Zhang Q; Zeng G; Zong S
    J Cell Biochem; 2020 Nov; 121(11):4542-4557. PubMed ID: 32048762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation.
    Boissy P; Andersen TL; Abdallah BM; Kassem M; Plesner T; Delaissé JM
    Cancer Res; 2005 Nov; 65(21):9943-52. PubMed ID: 16267019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased signaling through p62 in the marrow microenvironment increases myeloma cell growth and osteoclast formation.
    Hiruma Y; Honjo T; Jelinek DF; Windle JJ; Shin J; Roodman GD; Kurihara N
    Blood; 2009 May; 113(20):4894-902. PubMed ID: 19282458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional osteoclast-like transformation of cultured human myeloma cell lines.
    Calvani N; Cafforio P; Silvestris F; Dammacco F
    Br J Haematol; 2005 Sep; 130(6):926-38. PubMed ID: 16156862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth factors in multiple myeloma: a comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarrays.
    Mahtouk K; Moreaux J; Hose D; Rème T; Meissner T; Jourdan M; Rossi JF; Pals ST; Goldschmidt H; Klein B
    BMC Cancer; 2010 May; 10():198. PubMed ID: 20465808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.